V V Mashin - JoVE Visualize

Showing results (21-30 of 31) with videos related to

Pageof 4

Sort By:

Pharmaceutical Chemistry Journal|May 16, 2022

Ensuring Viral Safety of Equine Immunoglobulins during ProductionV V Mashin, A N Sergeev, N N Martynova, et al.

Vrachebnoe Delo|April 1, 1991

[The improved differential diagnosis and pathogenetic therapy of initial forms of cerebrovascular disorders]V D Khobta, I A Diordienko, V I Zlobina, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 29, 2023

[Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection]L A Belova, V V Mashin, D R Dolgova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 19, 2019

[Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period]V V Mashin, L A Belova, I F Aizatullin, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 26, 2012

[Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]L A Belova, V V Mashin, O Iu Kolotik-Kameneva, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 26, 2023

[Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)]V V Mashin, L A Belova, E Y Kotova, et al.

Pharmaceutical Chemistry Journal|July 18, 2022

Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/SerumV V Mashin, A N Sergeev, N N Martynova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 29, 2022

[Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)]N N Zavadenko, N Y Suvorinova, T T Batysheva, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 28, 2022

[Treatment of attention deficit hyperactivity disorder in children: results of a multicenter, randomized, double-blind, placebo-controlled clinical trial]N N Zavadenko, E V Makushkin, D D Gaynetdinova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 3, 2025

[Results of the international multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of the sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (MIR)]N A Shamalov, A I Fedin, G S Rakhimbaeva, et al.

Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:

Pageof 4

Pharmaceutical Chemistry Journal|May 16, 2022

Ensuring Viral Safety of Equine Immunoglobulins during ProductionV V Mashin, A N Sergeev, N N Martynova, et al.

Vrachebnoe Delo|April 1, 1991

[The improved differential diagnosis and pathogenetic therapy of initial forms of cerebrovascular disorders]V D Khobta, I A Diordienko, V I Zlobina, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 29, 2023

[Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection]L A Belova, V V Mashin, D R Dolgova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 19, 2019

[Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period]V V Mashin, L A Belova, I F Aizatullin, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 26, 2012

[Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]L A Belova, V V Mashin, O Iu Kolotik-Kameneva, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 26, 2023

[Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)]V V Mashin, L A Belova, E Y Kotova, et al.

Pharmaceutical Chemistry Journal|July 18, 2022

Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/SerumV V Mashin, A N Sergeev, N N Martynova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 29, 2022

[Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)]N N Zavadenko, N Y Suvorinova, T T Batysheva, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 28, 2022

[Treatment of attention deficit hyperactivity disorder in children: results of a multicenter, randomized, double-blind, placebo-controlled clinical trial]N N Zavadenko, E V Makushkin, D D Gaynetdinova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 3, 2025

[Results of the international multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of the sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (MIR)]N A Shamalov, A I Fedin, G S Rakhimbaeva, et al.

Pageof 4